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The most common method for measuring cell-mediated
cytotoxicity is the release assay. Effector cell-mediated dis-
ruption of the target cell membrane results in leakage of
its cytoplasmic contents into the culture medium. Endo-
genous biomolecules (such as lactate dehydrogenase) or
previously added exogenous labels (such as the radioiso-
topes Cr51 or In111) that leak into the media are then mea-
sured as an indirect readout of the damage caused by
effector cells. Alternative endpoint methods include flow
cytometry, ELISA-based granzyme measurement, and
morphometric analyses by microscopy.
Here we describe an automated impedance-based assay
that in a real-time and label-free manner captures the
kinetics of cell-mediated or antibody-dependent cell-
mediated cytolysis (ADCC) of cancer cells. Specifically, the
xCELLigence system was used to monitor the response of
tumor cells to natural killer (NK) cell activity in the pre-
sence or absence of an immunoglobulin G isotype-specific
antibody. Importantly, we show that the addition of NK
cells in suspension over a monolayer of adherent tumor
cells does not cause impedance changes because the NK
cells do not come in contact with the electronic sensor.
However, in the presence of antibody these non-adherent
NK cells inject perforins and granzymes into the tumor
cells, causing apoptosis. The resultant morphological
changes, death, and detachment of the tumor cells are
readily detected via changes in impedance.
Overall, our results show that the impedance-based
xCELLigence technology provides a direct, sensitive, and
specific measurement of target cell changes over the short
(hours) and long (days) time regimes. It enables facile
quantification of cell-mediated cytotoxicity and evaluation
of the potencies of specific antibodies.
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